Author

D. E. Quelle

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

C. A. Kaemmer· 3 shared D. K. Meyerholz· 2 shared M. R. Leidinger· 2 shared A. H. Mahalingam· 1 shared A. M. Bellizzi· 1 shared A. Sadanandam· 1 shared B. W. Darbro· 1 shared C. Bauchle· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

C. A. Kaemmer

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Inhibition of serotonin biosynthesis in neuroendocrine neoplasm suppressestumor growth in vivo

D. H. Tow, C. G. Tran, L. C. Borbon, M. Ridder, G. Li, C. A. Kaemmer, E. Abusada, A. H. Mahalingam, A. Sadanandam, C. Chandrasekharan, J. Dillon, D. R. Spitz, D. E. Quelle, C. H. F. Chan, A. M. Bellizzi, , P. H. Ear

This study shows that inhibiting serotonin biosynthesis in neuroendocrine neoplasms reduces tumor growth in vivo but not in vitro.

bioRxiv · Apr 7, 2023 · PreprintCancer Biology

Oncogenic RABL6A promotes NF1-associated MPNST progression in vivo

J. L. Kohlmeyer, C. A. Kaemmer, J. J. Lingo, M. R. Leidinger, D. K. Meyerholz, M. R. Tanas, R. D. Dodd, D. E. Quelle

This study shows RABL6A promotes NF1-associated MPNST progression in vivo, with loss of RABL6A leading to slower tumor growth and upregulated p27, but also paradoxical Myc elevation and hyper-proliferative tumors.

bioRxiv · Jul 7, 2021Cancer Biology

RABL6A promotes pancreatic neuroendocrine tumor angiogenesis and progression in vivo

C. K. Maharjan, C. A. Kaemmer, V. P. Muniz, C. Bauchle, S. L. Mott, K. D. Zamba, P. Breheny, M. R. Leidinger, B. W. Darbro, S. Stephens, D. K. Meyerholz, D. E. Quelle

This study shows RABL6A promotes pancreatic neuroendocrine tumor angiogenesis and progression in vivo by affecting tumor formation, angiogenesis, and survival.

bioRxiv · Mar 17, 2021Cancer Biology